Member Info for HedgeHogarth

Not a chance Vlad would has sold any share OR exercised his options

We'll get an RNS I assume next week to confirm the 2nd tranche have vested

However, these have a 4 year expiry and I do not see Vlad exercising until the compnany is bought out

He has other options at 9p I think

Ignore them Tilly.

Do one then Micky - take your 4p and go and buy shares in something else

We are 4p now, we were 2p 4 weeks ago. we were 6p 6 hours ago....

WHo know's where we will be in 1 hour or 1 week..

Hemo are Clincial - only about 50% of new drugs make it this far.

Still a long way to go though - but Hemo CAR-T has moved from having a 1-2% chance of making it commercial to a 10% chance. PLan A is to acheieve great results in Phase 1 trials whilcl will start soon - if results are good it will be very good news for everyone

Trojan - just trades that are being reported late. MMs do it all the time to stop us all seeing what is really happening

Slacker - that sounds like a very ignorant comment

Suggest you do some research on Biotech

Haddy - It has only been a few hour ssince news. You cant judge the share price so soon after 100m shares have been traded.

MMs will quote for 1m shares right now - alnosy £50ks worth - make no mistake, they want you shares as there are buyers waiting,

I would no call it manipulation - but lets call it the normal pattern to make a market.

Fighting talk HT - arent you the grown up

You also missed the sarcasm in my note

Yes - I did beleive this will be 6/7/8p - and last time i checked there have been trades go through at 6p +

I'm still of the belief we will end the day much higher than where we are now

As for MMAG - You are very wrong. (1) I have not made a huge loss (2) I do no ramp, i've just tried to counter the sort of rubbish that pople like you may come out with - did you see that the mult-millionaire and very successful entrprenuer added another 0.5% to his holding today - he now holds 1.5% at a 10.5p average. I'm intent on making some very decent money there :-)

Nice sign - I wonder whether he will feature in the new ownership and whether he's in conversations with Music Magpie? He is clearly on their radar

Carry on Micky - keep up the ridiculous comments and sell up mate. I'm sure you are right, we wont see 6p for years and trials will probably never start

HT - just sell up chap, this share is not for you, +10% on todays news is rubbish as you say

I'll take one for the team and take anyone's shares off them at 4.4p.

NOt sure what all the fuss is about - you'd think Hemo has done something special

;-)

We've seen many of the sell come through as late reported

We are now seeing the big buys - likeng the 686,08 at 9.25am :-)

The MMs must be having all sorts of fun and games dealing with this volume

Remaining in the 'offer period' affords both MMAG and potential suitors a number of exemptions form the normal takeover code.

Prevail have been leading in respect of bringing investors together - they previously were 'lead investor' in PolyPhotonix in a £10m investments

https://theophthalmologist.com/business-profession/in-agreement

The way i see it...

Great RNS - encouraged lots of buying; a lot of which would have been >5p and even higher

They may have been a fair bit of selling too - but most LTHers will still be retaining majority of their shares

So - in my ind it is almost inevitable we'll see 6-7-8p very soon - if not today, then next week.

No chance of Placing today as the compnay has already exhausted its annual quote for shares.

Prevail took a 1% investent in Hemo at 6p prior to FDA approval. The consensus aongst most long term holders is that the funding will come via Prevail - probably as lead investor and may not come at a discount.

Valuation has been discussed on here for years!

The general consensus is that a market cap of c£100m is very realistic and appropriate for a Biotech making this signifcant breakthrough.

Its still only one more step on the ladder; Good results for CAR-T in Phase 1 will send this very high indeed and Hemo has a 2nd clcincial candidate in CBR which has the genuine potential to surpass anything we could imagine. Its being tested in US Gov controlled labs on live versions of the worlds deadliest viruses and has also shown proof on concept on cancer tumours

Hats off to Vlad and the team

And lets not forget the biggest and most exciting reason we are all here

C B R :-)

Thanks to a few de-rampers for your comedy attempts to downplay....

As hard as the clincial hold was to receive 7 months ago - it has GONE now :-)

HEMO CAR-T is safer as a result and HEMO will have learnt more and refined a number of aspects in that time

Prevail are lines up to kick off trials with 'realtime ' results available to Hemogenyx.

This als started with some very clever mice that have as close to a human immune system as any other mice that came before them - that gives me extra confidence and optimism going into trials

Raise a glass to Vlad and his Mighty Mice

Apologies to JD Sports s/holders. Just responding to LongerGuy. Its not a cross ramp

I've been in HEMO for 4 years and the RNS that Ive been waiting for for 4 years landed today. They are now officially a Clincial Biotech. The SP has done well in the last 4 weeks, so some of the rise has been in anticipation but myself and other LTHers believe an mcap of up to £100m is reasonable now which is more than double the current SP

The 2 others that I have shoed genuine conviction to are:

MMAG - currently priced to fail, but I am confident it is still a good business. It released encouraging H2 results before xmas and a successful entrpreneur bought 1% at 11p a share at the start of January. I believe 30-50p is the right value and the company is in an 'offer period' seeking a buyer

XPF - This company ownes two big up and coming leisure brands. Escape Hunt (Escape Rooms) and Boom Battle Bars. Share price has yet to react to a number of very strong trading updates. It has doubled revenue 2 years on the trot and is still growing. I'm targeting 30-40p

All HIGH risk - but with HIGH risk comes the possibility of HIGH reward

This is the news we were all waiting for - there was absolutley no guarantee that today was come. As Long Term shareholders in Hemo we have experienced 2-3 False dawns and a few dark days.

This affirms Hemogenyx science - teh FDA are bascially satisfied that Hemo CAR-T is safe to test on Humans.

So many drugs and therapies never make it to this signifcant milestone AND many Biotechs fail to make it here too. Those that do have usually spent a LOT more than Hemogenyx.

I'm 100% confident that this underpins a market value of c£100m (which would be a share price of c.9pence

However, share prices do not go up in a straightline (very often) so we should expect volatility and some MM tactics to maintain a market.

Goatilicious

So much to learn in this game; be VERY careful investing any significant sums of money until you've done a good year or so of investing small amounts.

Shorting is not as bad as it sounds - but can be damaging to some compnaies, particularly smaller ones. The shorters dont hang around for ever and the shares usually get a good bounce when the shorters have to buy back the shares to return to lender - see what i did there :-)

If the game was easy - everyone would make money

Best to invest with a 3-5 year minimum horizon

Dont invest in too many different shares as you won't have time to stay well researched

Often the best time to buy is when others are fearful - I would happily buy JD Sports right now - with a 3-5 year horizon

I'm currently playing a riskier game and in 3 of 4 shares I think are materially undervalued and expect them to re-rate within weeks/months. But never any guarantees and easy to get big calls wrong